Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Diabetes Mellitus, Type 2 3Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Lung Neoplasms 1Disease 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Standard of Care 3X-Rays 2Educational Status 2Bronchoscopy 2Blood Specimen Collection 2vilanterol 1tocilizumab 1perflutren 1Tomography, X-Ray Computed 1Tiotropium Bromide 1Therapeutics 1Telemedicine 1Tablets 1Symptom Assessment 1Surgical Procedures, Operative 1Sulfur Hexafluoride 1Sulfonylurea Compounds 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Singing 1Salmeterol Xinafoate 1Rehabilitation 1Pulmonary Surgical Procedures 1Prednisolone 1Practice Guidelines as Topic 1Pharmacists 1Palliative Care 1Methods 1Massage 1Magnesium Sulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Disease, Chronic Obstructive × Dipeptidyl-Peptidase IV Inhibitors × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡